The pathogenesis of Lassa fever is poorly understood. As the liver is a major target organ of Lassa virus, gene expression in Lassa virus-infected HuH-7 cells, a differentiated human hepatoma cell line, was studied. Cellular mRNA levels were measured at the late phase of acute infection, when virtually all cells expressed large amounts of nucleoprotein, and virus RNA concentration had reached >108 copies (ml supernatant)−1. Two types of transcription array were used: cDNA-based macroarrays with a set of 3500 genes (Atlas Human 1.2 arrays; Clontech) and oligonucleotide-based microarrays covering 18 400 transcripts (Human Genome U133A array; Affymetrix). Data analysis was based on statistical frameworks controlling the false-discovery rate. Atlas array data were considered relevant if they could be verified by U133A array or real-time RT-PCR. According to these criteria, there was no evidence for true changes in gene expression. Considering the precision of the U133A array and the number of replicates tested, potential expression changes due to Lassa virus infection are probably smaller than twofold. To substantiate the array data, beta interferon (IFN-β) gene expression was studied longitudinally in Lassa virus-infected HuH-7 and FRhK-4 cells by using real-time RT-PCR. IFN-β mRNA levels increased only twofold upon Lassa virus infection, although there was no evidence that the virus inhibited poly(I : C)-induced IFN-β gene expression. In conclusion, Lassa virus interferes only minimally with gene expression in HuH-7 cells and poorly induces IFN-β gene transcription.
AsperM.,
SternsdorfT.,
HassM.,
DrostenC.,
RhodeA.,
SchmitzH.,
GüntherS.2004; Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol 78:3162–3169[CrossRef]
BaizeS.,
KaplonJ.,
FaureC.,
PannetierD.,
Georges-CourbotM. C.,
DeubelV.2004; Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J Immunol 172:2861–2869[CrossRef]
BaldiP.,
LongA. D.2001; A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17:509–519[CrossRef]
BaslerC. F.,
WangX.,
MuhlbergerE.,
VolchkovV.,
ParagasJ.,
KlenkH. D.,
Garcia-SastreA.,
PaleseP.2000; The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 97:12289–12294[CrossRef]
DeBiasiR. L.,
ClarkeP.,
MeintzerS.,
JotteR.,
Kleinschmidt-DemastersB. K.,
JohnsonG. L.,
TylerK. L.2003; Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J Virol 77:8934–8947[CrossRef]
DouJ.,
LiuP.,
ZhangX.2005; Cellular response to gene expression profiles of different hepatitis C virus core proteins in the Huh-7 cell line with microarray analysis. J Nanosci Nanotechnol 5:1230–1235[CrossRef]
FukutomiT.,
ZhouY.,
KawaiS.,
EguchiH.,
WandsJ. R.,
LiJ.2005; Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression. Hepatology 41:1096–1105[CrossRef]
GeissG. K.,
AnM. C.,
BumgarnerR. E.,
HammersmarkE.,
CunninghamD.,
KatzeM. G.2001; Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol 75:4321–4331[CrossRef]
GeissG. K.,
CarterV. S.,
HeY.,
KwieciszewskiB. K.,
HolzmanT.,
KorthM. J.,
LazaroC. A.,
FaustoN.,
BumgarnerR. E.,
KatzeM. G.2003; Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol 77:6367–6375[CrossRef]
GirardS.,
ShalhoubP.,
LescureP.,
SabileA.,
MisekD. E.,
HanashS.,
BrechotC.,
BerettaL.2002; An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295:272–283[CrossRef]
GirardS.,
VossmanE.,
MisekD. E.,
PodevinP.,
HanashS.,
BrechotC.,
BerettaL.2004; Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses. Hepatology 40:708–718[CrossRef]
HayashiJ.,
StoyanovaR.,
SeegerC.2005; The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon. Virology 335:264–275[CrossRef]
KashJ. C.,
MuhlbergerE.,
CarterV.,
GroschM.,
PerwitasariO.,
ProllS. C.,
ThomasM. J.,
WeberF.,
KlenkH. D.,
KatzeM. G.2006; Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J Virol 80:3009–3020[CrossRef]
LiK.,
ProwT.,
LemonS. M.,
BeardM. R.2002; Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells. Hepatology 35:1237–1246[CrossRef]
LiK.,
ChenZ.,
KatoN.,
GaleM.Jr,
LemonS. M.2005; Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem 280:16739–16747[CrossRef]
LocarniniS.,
ShawT.,
DeanJ.,
ColledgeD.,
ThompsonA.,
LiK.,
LemonS. M.,
LauG. G.,
BeardM. R.2005; Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. J Clin Virol 32:113–121[CrossRef]
MahantyS.,
HutchinsonK.,
AgarwalS.,
McRaeM.,
RollinP. E.,
PulendranB.2003; Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 170:2797–2801[CrossRef]
Martinez-SobridoL.,
ZunigaE. I.,
RosarioD.,
Garcia-SastreA.,
de la TorreJ. C.2006; Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 80:9192–9199[CrossRef]
McCormickJ. B.,
WalkerD. H.,
KingI. J.,
WebbP. A.,
ElliottL. H.,
WhitfieldS. G.,
JohnsonK. M.1986; Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am J Trop Med Hyg 35:401–407
McCormickC. J.,
ChallinorL.,
MacdonaldA.,
RowlandsD. J.,
HarrisM.2004; Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system. J Gen Virol 85:429–439[CrossRef]
NakabayashiH.,
TaketaK.,
MiyanoK.,
YamaneT.,
SatoJ.1982; Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42:3858–3863
O'DonnellS. M.,
HolmG. H.,
PierceJ. M.,
TianB.,
WatsonM. J.,
ChariR. S.,
BallardD. W.,
BrasierA. R.,
DermodyT. S.2006; Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus. J Virol 80:1077–1086[CrossRef]
PrescottJ.,
YeC.,
SenG.,
HjelleB.2005; Induction of innate immune response genes by Sin Nombre hantavirus does not require viral replication. J Virol 79:15007–15015[CrossRef]
SchmitzH.,
KöhlerB.,
LaueT.,
DrostenC.,
VeldkampP. J.,
GüntherS.,
EmmerichP.,
GeisenH. P.,
FleischerK.other authors2002; Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect 4:43–50[CrossRef]
ScholleF.,
LiK.,
BodolaF.,
IkedaM.,
LuxonB. A.,
LemonS. M.2004; Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis. J Virol 78:1513–1524[CrossRef]
TalonJ.,
HorvathC. M.,
PolleyR.,
BaslerC. F.,
MusterT.,
PaleseP.,
Garcia-SastreA.2000; Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996[CrossRef]
TangB. S.,
ChanK. H.,
ChengV. C.,
WooP. C.,
LauS. K.,
LamC. C.,
ChanT. L.,
WuA. K.,
HungI. F.other authors2005; Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. J Virol 79:6180–6193[CrossRef]
ZhouH.,
PerlmanS.2007; Mouse hepatitis virus does not induce beta interferon synthesis and does not inhibit its induction by dsRNA. J Virol 81:568–574[CrossRef]